Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Galena Biopharma In (GALE)

Galena Biopharma In (GALE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Galena Biopharma In 2000 Crow Canyon Place Suite 380 San Ramon CA 94583 USA

www.galenabiopharma.com P: 855-855-4253

Description:

Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.

Key Statistics

Overview:

Market Capitalization, $K 11,885
Shares Outstanding, K 45,710
Annual Sales, $ 0 K
Annual Net Income, $ -23,550 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,080 K
60-Month Beta 1.99
% of Insider Shareholders 0.76%
% of Institutional Shareholders 16.62%

Growth:

1-Year Return -87.32%
3-Year Return -99.17%
5-Year Return -99.27%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -62.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 08/14/17
Next Earnings Date 11/08/17
Earnings Per Share ttm -0.98
EPS Growth vs. Prev Qtr 6.25%
EPS Growth vs. Prev Year 62.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 11/14/16

GALE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.98%
Return-on-Assets % -33.82%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 0.38
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar